Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tongshu Biotech
Shanghai, Shanghai, Chinatongshugene.com ↗
- Ownership
- Private
- Employees
- ~400
- Development stage
- Other
01
Overview
Tongshu Biotech is a leading Chinese high-tech enterprise specializing in precision oncology and molecular diagnostics. The company develops and commercializes high-throughput sequencing (NGS) and PCR-based diagnostic kits for cancer screening, companion diagnostics, and minimal residual disease (MRD) monitoring. Their flagship OncoVee platform provides comprehensive genomic profiling to guide personalized treatment for various solid tumors. With dual headquarters and manufacturing bases in Shanghai and Nanjing, the company supports clinical decision-making through a robust portfolio of NMPA-approved IVD products and centralized laboratory services.
- Therapeutic areas
- Oncology
- Modalities
- Molecular diagnosticNext-Generation SequencingPolymerase Chain Reaction
- Industry
- Molecular Diagnostics
02
Partnerships
Beyond the preview
Go deeper on Tongshu Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tongshu Biotech.